Osteonecrosis due to drugs of unspecified carpus
ICD-10 M87.139 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs of unspecified carpus.
Osteonecrosis, also known as avascular necrosis, is a condition characterized by the death of bone tissue due to a lack of blood supply. In the case of M87.139, the osteonecrosis is specifically attributed to the use of certain drugs, which can disrupt blood flow to the bones. This condition can occur in various locations within the body, but when it affects the carpal bones, it can lead to significant pain, limited range of motion, and potential joint dysfunction. The carpus, consisting of eight small bones in the wrist, is particularly susceptible to osteonecrosis due to its complex vascular supply. Common drugs associated with this condition include corticosteroids and certain chemotherapy agents. Clinically, patients may present with wrist pain, swelling, and decreased function. Diagnosis typically involves imaging studies such as MRI or X-rays to assess bone integrity and blood flow. Treatment options may include conservative management, such as physical therapy and pain relief, or surgical interventions like core decompression or joint replacement in severe cases. Understanding the etiology and management of drug-induced osteonecrosis is crucial for effective patient care and coding accuracy.
Detailed history of drug use, imaging results, and treatment plans.
Patients presenting with wrist pain after corticosteroid therapy.
Ensure clear documentation of the relationship between drug use and osteonecrosis.
Comprehensive medication history and assessment of joint function.
Patients with autoimmune conditions on long-term corticosteroids developing wrist pain.
Document the rationale for drug use and monitoring for side effects.
Used for pain management in patients with osteonecrosis.
Document indication for the procedure and any imaging performed.
Orthopedic specialists should ensure clear documentation of the joint involved.
Corticosteroids, certain chemotherapy agents, and bisphosphonates are commonly associated with osteonecrosis.
Diagnosis typically involves a combination of patient history, physical examination, and imaging studies such as MRI or X-rays.
Treatment may include conservative management like physical therapy and pain relief, or surgical options such as core decompression or joint replacement.
